hemophilia

The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.

Lauren Killgore first learned about her health insurance company’s new policy at the beginning of 2017, when her husband, a 26-year-old hemophiliac, had…

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn't worked to bring costs down.

Hemophiliac patients participating in the Medicaid program could have more options for treatment in Florida this year. The Florida Agency for Health Care…